Recently, China Association of Reproductive Health Industry (CARHI) issued the Circular of China Association of Reproductive Health Industry on Approval of New Members (CARHI [2021] No. 2) to all member units. According to the Constitution of China Association of Reproductive Health Industry, the application for membership of Guangzhou Baiyunshan Weiyi Industry Co., Ltd (hereinafter referred to as: Baiyunshan Weiyi Industry) was passed on 22 January 2021 after the review by the Secretariat of the Association, and Baiyunshan Weiyi Industry was approved to be a member of China Association of Reproductive Health Industry.

          China Reproductive Health Industry Association was formally established in 2007, by the National Health and Family Planning Commission in charge of the Ministry of Civil Affairs approved the establishment of the National Reproductive Health Industry Association, is committed to maintaining the market order, standardise corporate behaviour, improve the research and development, production and promotion of new technologies and products for reproductive health products, improve the safety, reliability and effectiveness of products, and continue to strengthen the overall level of China's reproductive health industry, and promote the development of China's reproductive health industry. It is committed to maintaining the market order, regulating the behaviour of enterprises, improving the ability of research and development, production and promotion of new technologies of reproductive health products, improving the safety, reliability and effectiveness of products, continuously strengthening the overall level of China's reproductive health industry, and promoting the healthy, steady and sustainable development of China's reproductive health industry.

          Baiyunshan Weiyi Industry, as an important member of Guangzhou Pharmaceutical Group and Guangzhou Pharmaceutical Baiyunshan in the field of health, relying on the Group's industrial chain resources advantage of hundreds of billions of yuan, and guided by the demand of consumers for "health and beauty", builds a C2B2M model integrating research, development, production and marketing, and makes use of the "Baiyunshan Weiyi Group", the "Baiyunshan Weiyi Group" and the "Baiyunshan Weiyi Group". "Baiyunshan Weiyi Industry Health JIT Supply Chain Management Platform" realises the transformation of the new ecological relationship and supply chain, and is committed to building a high-quality health management service supply chain platform.

           In recent years, the growing demand for female reproductive health products and services in China has driven the development of the reproductive health industry. It is said that "a healthy woman, a happy family and a harmonious society", which shows the significance of women's health to the development of family and society. Adhering to the health concept of "caring for women's intimate health, helping women to achieve beauty from the inside out", Baiyunshan Weiyi Industry has been selected as a member of the China Association of Reproductive Industry, which will give full play to the demonstration effect of Baiyunshan Weiyi Industry in the field of women's reproductive health, and further help China's women's reproductive health project.

           With the increasing number of working women, women are not only busy with work but also take care of their families. They often shuttle between work and life, and neglect their own health. Under the huge market demand of "her health", in December 2020, Baiyunshan Weiyi Industry launched a probiotic product for women's intimate care - cranberry probiotic solid drink.